| Rfx6 directs islet formation and insulin production in mice and humans SB Smith, HQ Qu, N Taleb, NY Kishimoto, DW Scheel, Y Lu, AM Patch, ... Nature 463 (7282), 775-780, 2010 | 405 | 2010 |
| Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover … N Taleb, A Emami, C Suppere, V Messier, L Legault, M Ladouceur, ... Diabetologia 59, 2561-2571, 2016 | 137 | 2016 |
| The challenges of achieving postprandial glucose control using closed‐loop systems in patients with type 1 diabetes V Gingras, N Taleb, A Roy‐Fleming, L Legault, R Rabasa‐Lhoret Diabetes, Obesity and Metabolism 20 (2), 245-256, 2018 | 114 | 2018 |
| Comparison of two continuous glucose monitoring systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at rest and during exercise N Taleb, A Emami, C Suppere, V Messier, L Legault, JL Chiasson, ... Diabetes technology & therapeutics 18 (9), 561-567, 2016 | 76 | 2016 |
| Glucagon in artificial pancreas systems: potential benefits and safety profile of future chronic use N Taleb, A Haidar, V Messier, V Gingras, L Legault, R Rabasa‐Lhoret Diabetes, Obesity and Metabolism 19 (1), 13-23, 2017 | 62 | 2017 |
| The benefits and limits of technological advances in glucose management around physical activity in patients type 1 diabetes S Tagougui, N Taleb, R Rabasa-Lhoret Frontiers in endocrinology 9, 818, 2019 | 60 | 2019 |
| Artificial pancreas systems and physical activity in patients with type 1 diabetes: challenges, adopted approaches, and future perspectives S Tagougui, N Taleb, J Molvau, É Nguyen, M Raffray, R Rabasa-Lhoret Journal of diabetes science and technology 13 (6), 1077-1090, 2019 | 46 | 2019 |
| Timing of insulin basal rate reduction to reduce hypoglycemia during late post-prandial exercise in adults with type 1 diabetes using insulin pump therapy: a randomized … A Roy-Fleming, N Taleb, V Messier, C Suppère, C Cameli, S Elbekri, ... Diabetes & metabolism 45 (3), 294-300, 2019 | 44 | 2019 |
| Body composition and epicardial fat in type 2 diabetes patients following insulin detemir versus insulin glargine initiation B Elisha, M Azar, N Taleb, S Bernard, G Iacobellis, R Rabasa-Lhoret Hormone and metabolic research 48 (01), 42-47, 2016 | 44 | 2016 |
| The promising future of insulin therapy in diabetes mellitus R Cheng, N Taleb, M Stainforth-Dubois, R Rabasa-Lhoret American Journal of Physiology-Endocrinology and Metabolism 320 (5), E886-E890, 2021 | 38 | 2021 |
| Prevalence and determinants of albuminuria in a cohort of diabetic patients in Lebanon N Taleb, H Salti, M Al-Mokaddam, M Merheb, I Salti, M Nasrallah Annals of Saudi Medicine 28 (6), 420-425, 2008 | 33 | 2008 |
| A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes … S Tagougui, N Taleb, L Legault, C Suppère, V Messier, I Boukabous, ... Diabetologia 63, 2282-2291, 2020 | 32 | 2020 |
| Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients HI Salti, MP Nasrallah, NM Taleb, M Merheb, S Haddad, J El-Annan, ... Canadian Journal of Ophthalmology 44 (3), 308-313, 2009 | 31 | 2009 |
| Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: results of an online survey N Taleb, V Messier, S Ott-Braschi, JL Ardilouze, R Rabasa-Lhoret Diabetes Research and Clinical Practice 144, 42-50, 2018 | 28 | 2018 |
| Changes in accuracy of continuous glucose monitoring using Dexcom G4 Platinum over the course of moderate intensity aerobic exercise in type 1 diabetes S Larose, R Rabasa-Lhoret, A Roy-Fleming, C Suppère, S Tagougui, ... Diabetes technology & therapeutics 21 (6), 364-369, 2019 | 25 | 2019 |
| Self-reported severe and nonsevere hypoglycemia in type 1 diabetes: population surveillance through the BETTER patient engagement registry: development and baseline characteristics AS Brazeau, V Messier, MK Talbo, C Gagnon, N Taleb, I Fortier, Z Wu, ... Canadian Journal of Diabetes 46 (8), 813-821, 2022 | 24 | 2022 |
| Vascular complications of diabetes in Lebanon: experience at the American University of Beirut N Taleb, H Salti, M Al-Mokaddam, M Merheb, I Salti, M Nasrallah The British Journal of Diabetes & Vascular Disease 8 (2), 80-83, 2008 | 20 | 2008 |
| Duration of catheter use in patients with diabetes using continuous subcutaneous insulin infusion: a review L Bonato, N Taleb, V Gingras, V Messier, F Gobeil, J Ménard, ... Diabetes technology & therapeutics 20 (7), 506-515, 2018 | 19 | 2018 |
| Minimizing the risk of exercise-induced glucose fluctuations in people living with type 1 diabetes using continuous subcutaneous insulin infusion: an overview of strategies J Molveau, R Rabasa-Lhoret, N Taleb, E Heyman, É Myette-Côté, ... Canadian journal of diabetes 45 (7), 666-676, 2021 | 18 | 2021 |
| Can somatostatin antagonism prevent hypoglycaemia during exercise in type 1 diabetes? N Taleb, R Rabasa-Lhoret Diabetologia 59, 1632-1635, 2016 | 17 | 2016 |
